SPECIFIC CHROMOSOMIC ALTERATIONS CONFER THERAPY RESISTANCE IN A COHORT OF 49 PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY

被引：0
|
作者：
Papayannidis, C. [1 ]
Fontana, M. [1 ]
Marconi, G. [1 ]
Guadagnuolo, V. [1 ]
Simonetti, G. [1 ]
Padella, A. [1 ]
Paolini, S. [1 ]
Abbenante, M. C. [1 ]
Parisi, S. [1 ]
Sartor, C. [1 ]
Lo Monaco, S. [1 ]
Manfrini, M. [1 ]
Zuffa, E. [1 ]
Franchini, E. [1 ]
Venturi, C. [1 ]
di Rora, A. Ghelli Luiserna [1 ]
Ottaviani, E. [1 ]
Martinelli, G. [1 ]
机构：
[1] Univ Bologna, DIMES, Bologna, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P064
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Survival and Outcomes after Relapse in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated with Venetoclax-Based Chemotherapy
    Chow, Lydia D.
    Chen, Denaly
    Vergara-Lluri, Maria E.
    Tam, Eric
    Woan, Karrune
    Chaudhary, Preet M.
    Yaghmour, George
    Ladha, Abdullah
    BLOOD, 2022, 140 : 9027 - 9028
  • [42] Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy
    Ghadiany, Mojtaba
    Rahimi, Hossein
    Rezvani, Hamid
    Mohammad Alizadeh, Afshin
    Zamani, Nasim
    Mehdizadeh, Mahshid
    Foratyazdi, Mohammad
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : E11 - E15
  • [43] Therapy for acute myeloid leukemia: intensive timing of induction chemotherapy
    Wells R.J.
    Woods W.G.
    Buckley J.D.
    Arceci R.J.
    Current Oncology Reports, 2000, 2 (6) : 524 - 528
  • [44] Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged " Early" after Intensive Induction Therapy
    Hunter, Cameron
    Cheng, Wei
    Halene, Stephanie
    Mendez, Lourdes
    Podoltsev, Nikolai A.
    Zeidan, Amer M.
    Barbarotta, Lisa
    Shallis, Rory M.
    BLOOD, 2023, 142
  • [45] Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States
    Bhatt, Vijaya Raj
    Shostrom, Valerie
    Gundabolu, Krishna
    Armitage, James O.
    BLOOD ADVANCES, 2018, 2 (11) : 1277 - 1282
  • [46] Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
    Apel, Arie
    Moshe, Yakir
    Ofran, Yishai
    Gural, Alexander
    Wolach, Ofir
    Ganzel, Chezi
    Canaani, Jonathan
    Zektser, Miri
    Duek, Adrian
    Stemer, Galia
    Hellman, Ilana
    Basood, May
    Frisch, Avraham
    Leibovitch, Chiya
    Koren-Michowitz, Maya
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : 790 - 795
  • [47] Comparison Of Epigenetic Versus Intensive Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia Patients ≥60 Years Old: The Roswell Park Experience
    Gupta, Neha
    Gandhi, Shipra
    Miller, Austin
    Ford, Laurie A.
    Griffiths, Elizabeth A.
    Thompson, James E.
    Wetzler, Meir
    Wang, Eunice S.
    BLOOD, 2013, 122 (21)
  • [48] Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
    Shallis, Rory M.
    Stahl, Maximilian
    Wei, Wei
    Montesinos, Pau
    Lengline, Etienne
    Neukirchen, Judith
    Bhatt, Vijaya R.
    Sekeres, Mikkael A.
    Fathi, Amir T.
    Konig, Heiko
    Luger, Selina
    Khan, Irum
    Roboz, Gail J.
    Cluzeau, Thomas
    Martinez-Cuadron, David
    Raffoux, Emmanuel
    Germing, Ulrich
    Umakanthan, Jayadev Manikkam
    Mukhereje, Sudipto
    Brunner, Andrew M.
    Miller, Adam
    McMahon, Christine M.
    Ritchie, Ellen K.
    Rodriguez-Veiga, Rebeca
    Itzykson, Raphael
    Boluda, Blanca
    Rabian, Florence
    Tormo, Mar
    Cruz, Evelyn Acuna
    Rabinovich, Emma
    Yoo, Brendan
    Cano, Isabel
    Podoltsev, Nikolai A.
    Bewersdorf, Jan Philipp
    Gore, Steven
    Zeidan, Amer M.
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1220 - 1225
  • [49] DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Tang, X.
    Cui, W.
    Jin, Z.
    Cao, J.
    Guo, D.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Fu, C.
    Han, Y.
    Ruan, C.
    Wu, D.
    HAEMATOLOGICA, 2016, 101 : 383 - 384
  • [50] Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy
    Lee, Sangmin
    Ritchie, Ellen K.
    Miah, Sumaiya
    Andy, Caroline
    Curcio, Tania
    Goudy, Finola
    Hovan, Michael
    Douglass, Claire
    Desai, Pinkal
    Samuel, Michael B.
    Roboz, Gail J.
    Satlin, Michael
    BLOOD, 2019, 134
12345